The filing says shares may be issued under the agreement, but gives no share count, price, or cash amount. It does not show whether Traws gains funding or whether current owners' shares become smaller.
The excerpt leaves out the deal's size and price, as well as how much cash Traws would receive. A stock sale could bring in funds and reduce each current owner's share, but the filing does not say which outcome applies here.
Follow Traws Pharma, Inc. (TRAW) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TRAW